Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism
- PMID: 29366768
- DOI: 10.1016/j.jep.2018.01.021
Ginseng polysaccharides enhanced ginsenoside Rb1 and microbial metabolites exposure through enhancing intestinal absorption and affecting gut microbial metabolism
Abstract
Ethnopharmacological relevance: Polysaccharides and small molecules commonly co-exist in decoctions of traditional Chinese medicines (TCMs). Our previous study outlined that ginseng polysaccharides (GP) could interact with co-existing ginsenosides to produce synergistic effect in an over-fatigue and acute cold stress model via gut microbiota involved mechanisms.
Aim of the study: This study aimed to verify the interactions by examining the impact of GP on oral pharmacokinetics of ginsenoside Rb1 (Rb1), the dominant protopanoxadiol (PPD)-type ginsenoside in Ginseng, on a dextran sulphate sodium (DSS) induced experimental colitis model which was characterized by gut dysbiosis, and to delineate the underlying mechanisms in vitro.
Materials and methods: Rats received drinking water (normal group), 5% DSS (UC group), or 5% DSS plus daily oral administration of GP (GP group) for 7 days and fecal samples were collected on day -3, 0 and 6. On day 7 all animals received an oral dosage of Rb1 and blood samples were withdrawn for pharmacokinetic study. The in vitro metabolism study of Rb1 in gut microbiota from normal and UC rats and the transport study of Rb1 across Caco-2 cell monolayer were carried out in presence/absence of GP. Rb1 and its bacterial metabolites ginsenoside Rd (Rd), ginsenoside F2 (F2), Compound K (CK) and PPD were determined using LC-MS/MS. Total and target bacteria in fecal samples were determined by using 16S rRNA-based RT-PCR. β-Glucosidase activity was determined by measuring 4-nitrophenol formed from 4-nitrophenyl-β-D-glucopyranoside hydrolysis.
Results: DSS induction did not alter AUC0-t and Cmax of Rb1, which, however, were doubled together with elevated AUC0-t of the metabolites, in particular Rd and CK, in GP group. GP influenced the microbial composition and showed a prebiotic-like effect. Accordingly, GP treatment could partially restore the β-glucosidase activity which was reduced by DSS induction. The presence of GP resulted in quicker microbial metabolism of Rb1 and higher Rd formation in first 8 h of incubation, while the impact on F2 and CK formation/conversion became obvious after 8 h. More interestingly, GP slightly stimulated Caco-2 cell growth and facilitated Rb1 transport across the Caco-2 monolayer in both directions, increasing the Papp of Rb1 from 10-7 cm/s to 10-6 cm/s.
Conclusions: GP alleviated DSS-induced colitis-like symptoms and enhanced the systemic exposure of Rb1 through enhancing microbial deglycosylation and intestinal epithelial absorption of Rb1. These findings further demonstrated the important role of gut microbiota in the multifaceted action of polysaccharides in the holistic actions of traditional decoction of TCMs.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Gut microbiota in the pharmacokinetics and colonic deglycosylation metabolism of ginsenoside Rb1 in rats: Contrary effects of antimicrobials treatment and restraint stress.Chem Biol Interact. 2016 Oct 25;258:187-96. doi: 10.1016/j.cbi.2016.09.005. Epub 2016 Sep 6. Chem Biol Interact. 2016. PMID: 27613481
-
Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.J Ethnopharmacol. 2021 Jan 30;265:113251. doi: 10.1016/j.jep.2020.113251. Epub 2020 Aug 15. J Ethnopharmacol. 2021. PMID: 32810615
-
Mechanism of antidiabetic and synergistic effects of ginseng polysaccharide and ginsenoside Rb1 on diabetic rat model.J Pharm Biomed Anal. 2018 Sep 5;158:451-460. doi: 10.1016/j.jpba.2018.06.024. Epub 2018 Jun 18. J Pharm Biomed Anal. 2018. PMID: 30032757
-
Review: Gut microbiota: Therapeutic targets of ginseng polysaccharides against multiple disorders.Int J Biol Macromol. 2025 Jan;287:138527. doi: 10.1016/j.ijbiomac.2024.138527. Epub 2024 Dec 9. Int J Biol Macromol. 2025. PMID: 39662561 Review.
-
Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?J Ethnopharmacol. 2016 Feb 17;179:253-64. doi: 10.1016/j.jep.2015.12.031. Epub 2015 Dec 23. J Ethnopharmacol. 2016. PMID: 26723469 Review.
Cited by
-
Ginseng polysaccharides: A potential neuroprotective agent.J Ginseng Res. 2021 Mar;45(2):211-217. doi: 10.1016/j.jgr.2020.09.002. Epub 2020 Sep 11. J Ginseng Res. 2021. PMID: 33841001 Free PMC article. Review.
-
The interactions between traditional Chinese medicine and gut microbiota: Global research status and trends.Front Cell Infect Microbiol. 2022 Sep 12;12:1005730. doi: 10.3389/fcimb.2022.1005730. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36171760 Free PMC article.
-
Iron Transport Tocopheryl Polyethylene Glycol Succinate in Animal Health and Diseases.Molecules. 2019 Nov 25;24(23):4289. doi: 10.3390/molecules24234289. Molecules. 2019. PMID: 31775281 Free PMC article. Review.
-
Cross-Talk between Gut Microbiota and the Heart: A New Target for the Herbal Medicine Treatment of Heart Failure?Evid Based Complement Alternat Med. 2020 Apr 6;2020:9097821. doi: 10.1155/2020/9097821. eCollection 2020. Evid Based Complement Alternat Med. 2020. PMID: 32328141 Free PMC article. Review.
-
Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.Int J Nanomedicine. 2020 Jun 3;15:3937-3951. doi: 10.2147/IJN.S247406. eCollection 2020. Int J Nanomedicine. 2020. PMID: 32581538 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous